Details for New Drug Application (NDA): 061905
✉ Email this page to a colleague
NDA 061905 describes E.E.S. 400, which is a drug marketed by Arbor Pharms Llc and Azurity and is included in two NDAs. It is available from one supplier. Additional details are available on the E.E.S. 400 profile page.
The generic ingredient in E.E.S. 400 is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
The generic ingredient in E.E.S. 400 is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
Summary for 061905
| Tradename: | E.E.S. 400 |
| Applicant: | Azurity |
| Ingredient: | erythromycin ethylsuccinate |
| Patents: | 0 |
Pharmacology for NDA: 061905
| Physiological Effect | Decreased Sebaceous Gland Activity |
Medical Subject Heading (MeSH) Categories for 061905
Suppliers and Packaging for NDA: 061905
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| E.E.S. 400 | erythromycin ethylsuccinate | TABLET;ORAL | 061905 | ANDA | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | 24338-100 | 24338-100-03 | 30 TABLET in 1 BOTTLE (24338-100-03) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 400MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 400MG BASE | ||||
| Approval Date: | Aug 12, 1982 | TE: | BX | RLD: | No | ||||
Complete Access Available with Subscription
